Search Results

You are looking at 201 - 210 of 1,309 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Vijaya Raj Bhatt, Mojtaba Akhtari, R. Gregory Bociek, Jennifer N. Sanmann, Ji Yuan, Bhavana J. Dave, Warren G. Sanger, Anne Kessinger, and James O. Armitage

distinguish between the entities. 4 Clinical characteristics might also be helpful in making the distinction, including no history of CML or myeloproliferative disorder, no evidence of chronic or accelerated phases of CML after induction therapy, and no

Full access

Jordan K. Schaefer, Amro Elshoury, Victoria R. Nachar, Michael B. Streiff, and Ming Y. Lim

General Anticoagulant Characteristics Anticoagulants recommended in current CAT treatment guidelines include low-molecular-weight heparin (LMWH), warfarin, and in recent years, the direct oral anticoagulants (DOACs). 4 Fondaparinux is also occasionally

Full access

Mohamedtaki A. Tejani, Anna ter Veer, Dana Milne, Rebecca Ottesen, Tanios Bekaii-Saab, Al B. Benson III, Deborah Schrag, Stephen Shibata, John Skibber, Martin Weiser, Neal Wilkinson, and Steven J. Cohen

. All data used in this study, including patient and treatment characteristics, were longitudinally abstracted from medical records by trained data managers at each of the 8 participating Member Institutions. Eligibility for the Outcomes Database for CRC

Full access

Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D. Trunk, Lisa Pappas, Benjamin Haaland, and Ignacio Garrido-Laguna

Guidelines; Version 2.2021) do not specify a preferred chemotherapy plus targeted therapy combination for the up-front management of fit patients with left-sided RAS/RAF WT mCRC. 10 Clearly there is a need to identify patient or tumor characteristics that

Full access

Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, and Xiaomei Ma

sociodemographic characteristics: age at diagnosis, sex, race, and Medicare Part D low-income subsidy, a marker for reduced out-of-pocket cost sharing and lower socioeconomic status. Receipt of influenza vaccination in the 12 months before ET diagnosis was included

Full access

Quisette P. Janssen, Jacob L. van Dam, Laura R. Prakash, Deesje Doppenberg, Christopher H. Crane, Casper H.J. van Eijck, Susannah G. Ellsworth, William R. Jarnagin, Eileen M. O’Reilly, Alessandro Paniccia, Marsha Reyngold, Marc G. Besselink, Matthew H.G. Katz, Ching-Wei D. Tzeng, Amer H. Zureikat, Bas Groot Koerkamp, Alice C. Wei, and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

with concurrent chemotherapy) or stereotactic body RT (SBRT) regimens of ≥5 Gy per fraction in 5 fractions. Data Collection and Definitions Prespecified data on patient demographics, tumor characteristics, treatment details, and clinical and

Full access

Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop

16 weeks after surgery. Characteristics of the study population are shown in Table 1 . The median age was 70 years and 52% were male. Use of ACT ACT was delivered to 66% (1,861/2,801) of the study population. Use rates remained stable

Full access

Vaia Florou, Christopher Nevala-Plagemann, Jonathan Whisenant, Patricia Maeda, Glynn W. Gilcrease, and Ignacio Garrido-Laguna

carcinomas of the breast. They share a lobulated pattern; express MUC1, MUC4, and mammaglobin 1 ; and are stained positive with periodic acid–Schiff and mucicarmine. In addition to morphology, a pathognomonic characteristic of MASC is the presence of the ETV

Full access

Wen-Zhuo He, Wan-Ming Hu, Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, and Liang-Ping Xia

selection flowchart is summarized in supplemental eFigure 1 . Statistical Analysis All statistical analyses were performed using SPSS Statistics, version 13.0 (SPSS Inc). Frequencies and descriptive statistics were used to report patient characteristics and

Full access

Johannes Uhlig, Michael Cecchini, Amar Sheth, Stacey Stein, Jill Lacy, and Hyun S. Kim

KRAS wild-type). Table 1. Patient and Tumor Characteristics According to Microsatellite Status Table 2. Patient and Tumor Characteristics According to KRAS Status CRC Mutation Status: Impact on OS and Interaction With Tumor Location For survival